Recap: Intrepid Potash Q1 Earnings

Intrepid Potash (NYSE:IPI) reported its Q1 earnings results on Wednesday, May 3, 2023 at 04:15 PM. Here’s what…

Intrepid Potash (NYSE:IPI) reported its Q1 earnings results on Wednesday, May 3, 2023 at 04:15 PM.

Here’s what investors need to know about the announcement.

Earnings

Intrepid Potash missed estimated earnings by 44.78%, reporting an EPS of $0.37 versus an estimate of $0.67.

Revenue was down $17.48 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.11 which was followed by a 3.98% drop in the share price the next day.

Here’s a look at Intrepid Potash’s past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate 0.94 1.74 1.99 1.95
EPS Actual 0.83 0.97 1.82 2.32
Revenue Estimate 50.30M 81.49M 88.58M 90.88M
Revenue Actual 66.68M 74.75M 91.74M 104.40M

To track all earnings releases for Intrepid Potash visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Avanos Medical, Inc. Reports Preliminary Q4 And FY23 Financial Results; Revises Preliminary 2024 Revenue Outlook; Sees Q4 Revenue $170M-$173M Vs $179.27M Est.; FY23 Revenue $670M-$673M Vs $679.27M Est. ; FY24 Revenue $685M-$705M Vs $714.43M Est.

Avanos Medical, Inc. (NYSE:AVNS) today reported selected, unaudited preliminary financial results for the fourth quarter and full-year ended December 31, 2023 and revised its preliminary revenue outlook for

AVNS